Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 3 1Phase 2 1Phase 1 1

Status

Recruiting 5

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 35Other hematologic neoplasm 18Plasma cell 17CNS 7Dermatologic 6Thoracic 5Head & Neck 5Gynecologic 5Sarcoma 3Myeloid 3Genitourinary 3Breast 3Gastrointestinal 2Classical hematology 2Other solid neoplasm 1Other neoplasm 1NET 1Endocrine 1

Conditions

Ovarian Neoplasms 136Endometrial Neoplasms 82Uterine Cervical Neoplasms 67Fallopian Tube Neoplasms 38Breast Neoplasms 38Colorectal Neoplasms 31Carcinoma, Non-Small-Cell Lung 29Pancreatic Neoplasms 21Neoplasms 20Prostatic Neoplasms 19Neoplasm Metastasis 19Triple Negative Breast Neoplasms 18Stomach Neoplasms 17Urinary Bladder Neoplasms 16Squamous Cell Carcinoma of Head and Neck 15Esophageal Neoplasms 15Carcinoma, Renal Cell 14Carcinoma, Ovarian Epithelial 14Melanoma 13Head and Neck Neoplasms 13Carcinoma, Hepatocellular 12Uterine Neoplasms 11Sarcoma 11Lung Neoplasms 11Cholangiocarcinoma 10Vulvar Neoplasms 9Small Cell Lung Carcinoma 9Rectal Neoplasms 9Carcinoma, Transitional Cell 9Mesothelioma 8

Interventions

Cyclophosphamide 2fludarabine phosphate 1fludarabine 1elacestrant 1abemaciclib 1Palliative Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recurrence × Gynecologic × 30 days × Clear all
NCT07166094 2026-06-02

RAINFOL-03

Genmab

Phase 3 Recruiting
660 enrolled
Gynecologic

Recurrence, Endometrial Neoplasms

NCT07617753 2026-06-01

DUAL-OV-CAR-NK

Beijing Biotech

Phase 1/2 Recruiting
36 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT06051695 2026-05-26

EVEREST-2

A2 Biotherapeutics Inc.

Phase 1/2 Recruiting
474 enrolled
GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Colorectal Neoplasms

NCT07209449 2026-05-22

A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
75 enrolled
Gynecologic

Recurrence, Endometrial Neoplasms

NCT06305299 2026-05-19

Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
27 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡